MI - Nursing Case Study

Pathophysiology

• Primary mechanism: Coronary artery occlusion due to atherosclerotic plaque rupture, leading to a blood clot formation, which blocks blood flow to a portion of the myocardium, causing ischemia and potential cell death.

• Secondary mechanism: Oxygen supply-demand mismatch resulting from the blockage, which exacerbates myocardial tissue damage, leading to necrosis if not promptly resolved, impacting heart function.

• Key complication: Inflammatory response and subsequent scar tissue formation can impair cardiac contractility and lead to heart failure or arrhythmias, highlighting the need for timely intervention and monitoring.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, nausea, diaphoresis

• Vital signs: Blood pressure 160/95 mmHg, Heart rate 110 bpm, Respiratory rate 24 breaths per minute, Temperature 37.4°C, Oxygen saturation 90% on room air

Section 1

After initial stabilization and administration of oxygen to improve saturation, the patient's chest pain intensity decreased slightly, but he continued to exhibit altered mental status and persistent dyspnea. An urgent ECG confirmed ST-segment elevation, consistent with an acute myocardial infarction (MI). Cardiac biomarkers were elevated, with troponin levels significantly above the normal range, confirming myocardial injury. In preparation for further treatment, he was administered nitroglycerin, which helped reduce his chest pain temporarily, and a beta-blocker was added to his regimen to lower heart rate and myocardial oxygen demand.

Despite these interventions, approximately an hour later, the patient began to exhibit signs of potential cardiogenic shock. His blood pressure dropped to 85/60 mmHg, and his heart rate increased to 125 bpm. Additional physical examination revealed cool, clammy skin with diminished peripheral pulses, suggesting decreased perfusion. This change in status prompted immediate reevaluation of his treatment strategy, considering emergent revascularization procedures such as percutaneous coronary intervention (PCI) and the initiation of inotropic support to improve cardiac output.

The clinical team also noted the presence of new crackles upon auscultation of the lungs, indicating the development of pulmonary edema, a complication associated with left ventricular dysfunction. The care team recognized the need for rapid intervention to address these signs of heart failure and prevent further deterioration. Diuretics were introduced to manage the fluid overload, and the patient was closely monitored in the intensive care unit to ensure swift response to any further complications. This progression underscored the necessity for continuous monitoring and adjustment of therapeutic strategies based on emerging clinical data and patient response.

Section 2

As the patient continued to receive intensive care, the clinical team closely monitored his response to the interventions. Despite the initial administration of diuretics, the patient's respiratory status showed minimal improvement, with persistent dyspnea and oxygen saturation levels fluctuating between 88-92% on supplemental oxygen. A repeat chest X-ray revealed worsening pulmonary congestion, consistent with increasing pulmonary edema. Recognizing the risk of acute respiratory failure, the team considered escalating respiratory support, contemplating non-invasive positive pressure ventilation to enhance oxygenation and reduce the work of breathing.

Simultaneously, laboratory results returned, providing further insight into his condition. Blood gas analysis indicated metabolic acidosis with a pH of 7.32, bicarbonate levels at 18 mEq/L, and an elevated lactate level of 5 mmol/L, suggesting poor tissue perfusion and anaerobic metabolism. Electrolyte imbalances were also noted, with a potassium level of 3.0 mEq/L, necessitating cautious correction to prevent arrhythmias, especially given the patient's ongoing cardiac instability. These findings highlighted the critical need for optimizing both cardiac and respiratory function to prevent further deterioration.

In response to the metabolic derangements and ineffective diuresis, the healthcare team adjusted the patient's treatment regimen. They initiated a low-dose infusion of norepinephrine to support blood pressure and enhance organ perfusion, while also increasing the dosage of diuretics to promote diuresis more effectively. Additionally, potassium supplementation was carefully administered to address the hypokalemia. The patient's condition demanded vigilant monitoring to assess the effectiveness of these interventions and to promptly identify any new complications, ensuring that the care plan remained dynamic and responsive to his evolving needs.

Section 3

As the patient continued under intensive care, the clinical team noted a change in his status. Despite the initiation of norepinephrine and increased diuretics, the patient's blood pressure remained marginally stable, with readings fluctuating between 85-95 mmHg systolic. His heart rate was noted to increase, ranging from 110 to 120 beats per minute, suggesting the heart's compensatory response to maintain perfusion. However, his oxygen saturation levels remained inconsistent, fluctuating between 86-90% even with non-invasive positive pressure ventilation. Clinically, the patient exhibited increased work of breathing, with accessory muscle use noted during assessment, and his respiratory rate increased to 28-32 breaths per minute. Auscultation revealed diffuse crackles throughout the lung fields, indicating persistent pulmonary congestion.

New laboratory results revealed further complications. The patient's renal function had deteriorated, with serum creatinine rising to 2.3 mg/dL, suggesting acute kidney injury potentially due to low perfusion states and aggressive diuresis. Despite potassium supplementation, his levels only improved slightly, now at 3.2 mEq/L, still placing him at risk for cardiac arrhythmias. The elevated lactate levels persisted, now at 6 mmol/L, underscoring ongoing inadequate tissue perfusion and anaerobic metabolism. The metabolic acidosis showed minimal improvement, with a pH of 7.33 and bicarbonate at 19 mEq/L.

These findings necessitated a reassessment of the current treatment strategy. The team considered the possibility of further escalating cardiovascular support, including the potential use of inotropic agents to enhance cardiac output and improve perfusion. Additionally, there was a discussion about the need for continuous renal replacement therapy to manage fluid overload and support renal function. The complexity of the patient's condition required a multidisciplinary approach, involving cardiology, nephrology, and critical care specialists to evaluate the best course of action to stabilize his condition and prevent further deterioration.

Section 4

As the clinical team continued to monitor the patient closely, they observed a notable change in his status. Despite the escalation of cardiovascular support with the addition of dobutamine to improve cardiac output, the patient's condition showed signs of further deterioration. His systolic blood pressure remained precariously low, now fluctuating between 80-88 mmHg, and his heart rate increased slightly to 125 beats per minute. The patient's respiratory distress was more pronounced, with a respiratory rate climbing to 34 breaths per minute and oxygen saturation levels dropping further to 82-85% despite maximum support from non-invasive positive pressure ventilation. The use of accessory muscles became even more apparent, and the patient was visibly fatigued from the increased work of breathing.

New diagnostic results provided insight into the evolving complications. A repeat chest X-ray indicated worsening pulmonary edema, with more pronounced bilateral infiltrates. Echocardiography revealed a reduced ejection fraction of 25%, confirming severe systolic dysfunction. Additionally, a repeat arterial blood gas analysis showed a further decline in metabolic status, with a pH of 7.29 and bicarbonate levels falling to 17 mEq/L, indicating worsening metabolic acidosis. The lactate level remained elevated at 6.5 mmol/L, highlighting persistent tissue hypoperfusion and anaerobic metabolism.

In light of these developments, the clinical team recognized the urgent need for additional interventions to stabilize the patient. The decision was made to initiate continuous renal replacement therapy to address the fluid overload and support the compromised renal function. Furthermore, discussions were initiated regarding the potential need for mechanical ventilation to relieve the patient's respiratory burden and optimize oxygenation. The complexity of the patient's condition underscored the need for continued multidisciplinary collaboration to navigate the challenges and improve his clinical trajectory.

Section 5

As the clinical team proceeded with the implementation of continuous renal replacement therapy (CRRT) to manage the patient's fluid overload and support renal function, they noted an initial positive response. Over the first few hours, the patient's fluid balance began to stabilize, and a slight improvement in oxygen saturation was observed, rising to 88-90%. However, despite these early signs of stabilization, the patient's cardiovascular status remained tenuous. His blood pressure continued to fluctuate, with systolic readings still hovering around 85 mmHg, and his heart rate remained elevated at 120 beats per minute. The team remained vigilant, aware that the patient's condition could change rapidly given the complexity of his presentation.

A crucial development occurred when the patient's hemodynamic parameters revealed a new complication. A pulmonary artery catheterization showed an increase in pulmonary artery pressures, indicating the onset of acute right heart failure. This was corroborated by an elevated central venous pressure of 18 mmHg. The team recognized that the worsening right ventricular dysfunction could further compromise cardiac output and exacerbate the pulmonary edema. This necessitated immediate consideration of advanced therapeutics to reduce afterload and manage the increased pulmonary pressures.

Further complicating the scenario, the patient's metabolic acidosis showed minimal improvement despite the initiation of CRRT, with a pH remaining at 7.31 and bicarbonate levels at 18 mEq/L. The persistent elevation of lactate at 6.0 mmol/L continued to signal inadequate perfusion and metabolic distress. Faced with these challenges, the multidisciplinary team engaged in a detailed discussion to evaluate the potential benefits of transitioning to mechanical ventilation. Such a move could decrease the patient's work of breathing, improve oxygenation, and potentially alleviate some of the hemodynamic burden on the heart. These considerations underscored the complexity of the patient's evolving condition and the need for precise clinical reasoning to navigate the path forward.